| UHC Surest Medical and Drug | Oncology Medication Clinical Coverage – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-09-01 |
| UHC Surest Medical and Drug | Vyepti® (Eptinezumab-Jjmr) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-09-01 |
| UHC Surest Medical and Drug | White Blood Cell Colony Stimulating Factors – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-09-01 |
| UHC UMR Medical and Drug | Intravenous Iron Replacement Therapy (Injectafer® & Monoferric®) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-09-01 |
| UHC UMR Medical and Drug | Oncology Medication Clinical Coverage – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-09-01 |
| UHC UMR Medical and Drug | Vyepti® (Eptinezumab-Jjmr) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-09-01 |
| UHC UMR Medical and Drug | White Blood Cell Colony Stimulating Factors – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-09-01 |
| UHC Commercial Medical & Drug | Intravenous Iron Replacement Therapy (Injectafer® & Monoferric®) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-09-01 |
| UHC Commercial Medical & Drug | Oncology Medication Clinical Coverage – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-09-01 |
| UHC Commercial Medical & Drug | Vyepti® (Eptinezumab-Jjmr) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-09-01 |